NCT01571466View on ClinicalTrials.gov

A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
HIV Infection
Interventions
DRUG

Vaccination

"* Modified Pox virus, strain MVA clade -B (expressing HIV-1 Bx08gp120 and IIIB gagpolnef)~ -\~ 1 x 10e8 pfu/ml~* 3 immunisations at week 0, 4 and 16"

DRUG

Placebo

3 immunisations at week 0, 4 and 16

Trial Locations (3)

28007

Hospital Universitario Gregorio Marañón, Madrid

08915

Hospital Universitari Germans Trias i Pujol, Badalona

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

All Listed Sponsors
lead

Hospital Clinic of Barcelona

OTHER

NCT01571466 - A Study to Evaluate the Safety of the HIV-1 Vaccine MVA-B in Chronic HIV-1 Infected Patients Successfully Treated With HAART | Biotech Hunter | Biotech Hunter